SCHEMBL2915607

SCHEMBL2915607

O=C(NC1CCCCC1)C(C1CCCCC1)C1(Cc2ccccc2)Nc2ccccc2N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 4/20 0.48
HPGD P15428 1/20 0.48
EPHX2 P34913 3/20 0.48
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
TSHR P16473 3/20 0.43
TP53 P04637 1/20 0.43
ALDH1A1 P00352 5/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907586 0.87 EPHX1 (0.41) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL3651896 0.84 EPHX1 (0.41) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL4042940 0.83 TSHR (0.45) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL3654059 0.81 EPHX1 (0.44) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL2912657 0.80 EPHX2 (0.51) EPHX1HPGDEPHX2RAB9ANPC1
SCHEMBL2912392 0.80 EPHX2 (0.48) EPHX1HPGDEPHX2RAB9ANPC1
SCHEMBL4755424 0.80 SMN1; SMN2 (0.42) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL4041915 0.80 SMN1; SMN2 (0.42) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL3652035 0.79 EPHX2 (0.47) EPHX1HPGDEPHX2TDP1SMN1; SMN2
SCHEMBL2912514 0.79 TP53 (0.40) EPHX1EPHX2SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed